Pfizer's Xeljanz cleared for ulcerative colitis in Europe
admin 1st August 2018 Uncategorised 0Drug becomes the first oral therapy and Janus kinase (JAK) inhibitor available for UC
More: Pfizer's Xeljanz cleared for ulcerative colitis in Europe
Source: News